Analyst Coverage

Firm Analyst Contact Information
Bank of America/Merrill Lynch   Derik de Bruin Phone: (646) 855-3100
Credit Suisse   Vamil Divan, MD Phone: (212) 538-5394
Cowen & Co.   Doug Schenkel Phone: (617) 946-3918
GARP Research & Securities   Rob Furlong Phone: (410) 318-5015
Goldman Sachs & Co.   Isaac Ro Phone: (212) 902-6393
Jefferies & Company   Jon Wood Phone: (212) 336-7227
JMP Securities, Inc.   J.T. Haresco Phone: (415) 869-4477
J.P. Morgan   Tycho Peterson Phone: (212) 622-6568
Ladenburg Thalmann & Co. Inc.   Kevin DeGeeter Phone: (212) 409-2027
Leerink Swann   Dan Leonard Phone: (212) 277-6616
Macquarie Research   Dan Leone Phone: (212) 231-6369
Mizuho Securities USA Inc.   Peter Lawson Phone: (212) 205-8474
Oppenheimer & Co. Inc.   David Ferreiro, Ph.D. Phone: (212) 667-8163
Piper Jaffray   William R. Quirk, CFA Phone: (612) 303-6858
RBC Capital Markets   Michael Yee Phone: (415) 633-8522
Stephens Inc.   Drew Jones Phone: (501) 377-2369
WallachBeth Capital LLC   Glen Losev Phone: (646) 998-7604
William Blair & Company   Amanda Murphy Phone: (312) 364-8951

Myriad Genetics, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Myriad Genetics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Myriad Genetics, Inc. or its management. Myriad Genetics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.


Stock Quote (NASDAQ:MYGN)

Price:
26.44
Change:
- 0.18
Open:
26.50
Previous Close:
26.62
Day High:
26.89
Day Low:
25.97
52 Week High:
38.27
52 Week Low:
22.02
Volume:
3,547,200
4:12 PM ET on Jun 18, 2013
Delayed at least 20 minutes.
Provided by eSignal.

Investor Contact

Scott Gleason
(801) 584-1143
sgleason@myriad.com

Media Contact

Ron Rogers
Corporate Communications and Media Relations
(801) 584-3065
rrogers@myriad.com

Shareholder Tools